Spyre Therapeutics's top three insider shareholders as of August 29, 2026 are Funds Management Llc Fairmount (Director, 4.02Mn shares), Funds Management Llc Fairmount (Director, 812.08K shares), Cameron Turtle (Chief Executive Officer, 567.54K shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Funds Management Llc Fairmount | Director | 0 | 4,018,101 | 4,018,101 | 78.2% | 25 Apr, 2024 |
| 2 | Cameron Turtle | Chief Executive Officer | 567,540 | 0 | 567,540 | 11.0% | 05 Aug, 2026 |
| 3 | Jonathan Alspaugh | Chief Financial Officer | 165,372 | 0 | 165,372 | 3.2% | 15 Mar, 2022 |
| 4 | Armen Shanafelt | Director | 150,000 | 0 | 150,000 | 2.9% | 13 Dec, 2021 |
| 5 | Scott L Burrows | Chief Financial Officer | 97,994 | 0 | 97,994 | 1.9% | 05 Aug, 2026 |
| 6 | Michael Thomas Henderson | Director | 68,606 | 0 | 68,606 | 1.3% | 23 Jun, 2026 |
| 7 | Jr. Michael Conick Hanley | Chief Commercial Officer | 36,200 | 0 | 36,200 | 0.7% | 10 Jun, 2022 |
| 8 | Anthony G. Quinn | President Ceo | 22,022 | 0 | 22,022 | 0.4% | 18 Mar, 2022 |
| 9 | Jeffrey W. Albers | Director | 0 | 9,360 | 9,360 | 0.2% | 10 Aug, 2026 |
| 10 | Marcio Souza | Director | 3,600 | 0 | 3,600 | 0.1% | 25 Aug, 2022 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 07 Aug, 2026 | Jeffrey W. Albers | Director | Acquired M | 5,000 | $10.39 | $51.95K | 5,000 | Direct |
| 07 Aug, 2026 | Jeffrey W. Albers | Director | Disposed S | 5,000 | $104.47 | $522.35K | 0 | Direct |
| 07 Aug, 2026 | Jeffrey W. Albers | Director | Disposed S | 8,000 | $104.38 | $835.04K | 19,360 | Indirect |
| 07 Aug, 2026 | Jeffrey W. Albers | Director | Disposed S | 10,000 | $104.68 | $1.05Mn | 9,360 | Indirect |
| 07 Aug, 2026 | Jeffrey W. Albers | Director | Disposed M | 5,000 | $0.00 | $0 | 45,000 | Direct |
| 03 Aug, 2026 | Scott L Burrows | Chief Financial Officer | Acquired M | 7,500 | $14.50 | $108.75K | 105,494 | Direct |
| 03 Aug, 2026 | Cameron Turtle | Chief Executive Officer | Disposed S | 800 | $93.97 | $75.18K | 581,740 | Direct |
| 03 Aug, 2026 | Cameron Turtle | Chief Executive Officer | Disposed S | 7,157 | $95.10 | $680.63K | 574,583 | Direct |
| 03 Aug, 2026 | Scott L Burrows | Chief Financial Officer | Disposed S | 5,100 | $95.21 | $485.57K | 100,394 | Direct |
| 03 Aug, 2026 | Cameron Turtle | Chief Executive Officer | Disposed S | 5,635 | $95.93 | $540.57K | 568,948 | Direct |
| 03 Aug, 2026 | Scott L Burrows | Chief Financial Officer | Disposed S | 2,300 | $96.30 | $221.49K | 98,094 | Direct |
| 03 Aug, 2026 | Scott L Burrows | Chief Financial Officer | Disposed S | 100 | $97.10 | $9.71K | 97,994 | Direct |
| 03 Aug, 2026 | Cameron Turtle | Chief Executive Officer | Disposed S | 1,392 | $96.82 | $134.77K | 567,556 | Direct |
| 03 Aug, 2026 | Cameron Turtle | Chief Executive Officer | Disposed S | 16 | $97.46 | $1.56K | 567,540 | Direct |
| 03 Aug, 2026 | Scott L Burrows | Chief Financial Officer | Disposed M | 7,500 | $0.00 | $0 | 344,857 | Direct |
| 01 Jul, 2026 | Scott L Burrows | Chief Financial Officer | Acquired M | 7,500 | $14.50 | $108.75K | 105,494 | Direct |
| 01 Jul, 2026 | Cameron Turtle | Chief Executive Officer | Disposed S | 10,176 | $87.44 | $889.79K | 587,364 | Direct |
| 01 Jul, 2026 | Sheldon Sloan | Chief Medical Officer | Acquired M | 8,334 | $27.46 | $228.85K | 8,334 | Direct |
| 01 Jul, 2026 | Sheldon Sloan | Chief Medical Officer | Disposed S | 6,500 | $87.52 | $568.88K | 1,834 | Direct |
| 01 Jul, 2026 | Scott L Burrows | Chief Financial Officer | Disposed S | 5,775 | $87.55 | $505.60K | 99,719 | Direct |